1. Introduction {#s0005}
===============

East Coast fever (ECF), a fatal bovine disease, is caused by the apicomplexan parasite *Theileria parva* ([@b0245])*.* The disease kills approximately one million cattle every year in Africa and causes significant economic losses to small-hold farmers in eastern, central and southern Africa of approximately \$300 million annually (reviewed in [@b0235]). These estimates were derived several years ago and it is highly likely that the current losses due to ECF are much larger. Vaccination against ECF by an infection and treatment method (ITM) is available ([@b0280]). For control of ECF in southern Africa, except South Africa where vaccination is not permitted as it is free of ECF, ITM is performed with a single parasite isolate, and in parts of eastern Africa a composite ITM vaccine, the Muguga cocktail, is used ([@b0220]). Although ITM confers solid and long-lived immunity it has disadvantages in that it is an unstable and potentially lethal product, and animals vaccinated by the ITM protocol remain life-long asymptomatic carriers of the parasite that pose risks for spread of the disease. It also requires a liquid nitrogen cold chain for storage and oxytetracycline for co-treatment (reviewed in [@b0075]). The vaccine is expensive and laborious to produce, and it requires skilled personnel for delivery (reviewed in [@b0075]). Therefore, development of a subunit vaccine that is easier to produce and with minimal risks is necessary.

Although classified in the phylum Apicomplexa, aspects of the biology of *Theileria* are atypical of such organisms. For example, *Theileria* sporozoites are not motile, they have a less defined apical complex and host cell entry is not orientation-specific ([@b0320]). Sporozoites bind and enter bovine lymphocytes by a ''zippering'' process of the host and the sporozoite cell membranes ([@b0120]). After entry into the host cell, rhoptries/microspheres are discharged with a rapid escape of the sporozoite from the surrounding host cell membrane. Sporozoites differentiate to the schizont stage, which resides in the host cytoplasm surrounded by host cell microtubules that are seemingly nucleated by parasite molecules (reviewed in [@b0320]). Schizont-infected cells acquire a cancer-like phenotype and are the cause of disease ([@b0245]). Sporozoites also bind and enter macrophages/afferent lymph veiled cells by a zippering process, but these cells are not susceptible to transformation and sporozoites appear to only differentiate to an early schizont stage ([@b0325]). Several host cell signalling pathways that contribute to host cell transformation have been studied ([@b0090], [@b0070]). In addition, parasite molecules that are associated with the transformation process have been tentatively identified by taking advantage of comparative genomics and cancer biology ([@b0330], [@b0150], [@b0355]). A parasite-encoded prolyl isomerase has been recently identified as playing a key role in this complex host cell transformation process ([@b0215]).

There is good evidence for roles of *T. parva* sporozoite and schizont antigens as candidate vaccine antigens. Several schizont antigens are targets of cytotoxic T lymphocytes (CTLs) that lyse schizont-infected cells ([@b0140], [@b0135], [@b0145]) and two sporozoite antigens are targets of neutralising antibodies ([@b0085], [@b0310]). One of the latter antigens, p67, has been shown to consistently protect a proportion of immunised cattle against challenge with needle-injected sporozoites and from infected ticks in field trials (reviewed in [@b0235]). The p67-based vaccine might be improved by including additional antigens that can neutralise sporozoite infectivity.

As a first step towards improving our molecular understanding of the biology of *T. parva* we have undertaken a Multidimensional Protein Identification Technology (MudPIT) LC--MS/MS approach (reviewed in [@b0300]) to characterise the proteome of *T. parva* sporozoites purified by ion-exchange chromatography ([@b0230]). We have employed bioinformatic tools to analyse 2007 parasite proteins that we were able to detect and identified *T. parva* orthologs of *Plasmodium falciparum* invasion organelle proteins, calcium signalling proteins and surface proteins. Some of these may represent novel *T. parva* vaccine candidates.

2. Materials and methods {#s0010}
========================

2.1. Animals and sporozoite production {#s0015}
--------------------------------------

The procedure for sporozoites production has been previously described in detail ([@b0265]). Briefly, cattle aged 7--9 months, previously managed under a strict acaricide regime, were maintained for at least 2 months and tested for exposure to *T. parva*, *Theileria mutans*, *Babesia bigemina* and *Anaplasma marginale* using ELISA and, in certain instances, with PCR analysis ([@b0225], [@b0250]). The naïve cattle were then inoculated with *T. parva* stabilates of the Muguga isolate and infection of the cattle was assessed. A colony of *Rhipicephalus appendiculatus* nymphs, previously tested for viruses such as Bovine Viral Diarrhea virus (BVDV) and Bunya viruses, and demonstrated to be free from tick-borne haemoparasites ([@b0265]), was then applied to the infected cattle. The fully-fed nymphs were collected and incubated for 6 weeks at 24 °C to induce moulting into adults and infection rates assessed by microscopy as described before ([@b0045]). A total of 300 adult ticks infected with *T. parva* Muguga isolate (mean infection rate of 167 acini per tick) were allowed to feed on rabbits to induce sporozoite maturation. After 4 days, the tick salivary glands were dissected from the ticks. All animal procedures described in this article were approved by International Livestock Research Institute's (ILRI, (Kenya)), Institute Animal Care and Use Committee (IACUC File Number 2014.01).

2.2. Sporozoite purification {#s0020}
----------------------------

Dissected tick salivary glands were collected in a tube with 2 ml of cold PBS, transferred to a chilled glass hand homogenizer ('UNI-FORM' (England), 4--5 ml of homogenizer) and disrupted by gentle up, down and circular motion of the pestle until a uniform cloudy suspension was formed. The suspension was then centrifuged at 1000*g* at 4 °C for 5 min. The resulting supernatant containing sporozoites was applied to an 8 ml diethylaminoethyl cellulose (DE-52; Sigma--Aldrich (USA) Cat. No. D3764) column ([@b0230]). Flow-through fractions of 3.5 ml were collected in siliconised 10 ml conical bottomed glass tubes on ice. The sporozoite-rich cloudy fractions (numbers 2--5) were pooled and centrifuged at 12,000*g* at 4 °C for 5 min. The resulting sporozoite-rich small yellowish pellet was resuspended in SDS--PAGE sample buffer and heated at 100 °C for 5 min prior to fractionation on 10% one-dimensional SDS--PAGE and staining with Coomassie Blue.

2.3. In-gel trypsin digestion for LC--MS/MS analysis {#s0025}
----------------------------------------------------

The gel lane containing sporozoite material was excised and divided into four fractions of different size proteins (\>100 kDa, 100--55 kDa, 55--35 kDa and \<35 kDa). The gel pieces were de-stained overnight in 50% methanol, 5% acetic acid in water. After dehydration with acetonitrile, proteins were reduced with 10 mM DTT in 100 mM ammonium bicarbonate, and subsequently alkylated using 50 mM iodoacetamide in ammonium bicarbonate for 30 min at room temperature. Following washing of the gel pieces in 100 mM ammonium bicarbonate, proteolytic digestion was carried out with 100 ng of trypsin in 50 mM ammonium bicarbonate overnight at 37 °C. Tryptic peptides were extracted from each gel with 50% acetonitrile, 5% acetic acid in water, dried and re-suspended in 20 μl of 2% acetonitrile, 0.1% formic acid in water for LC--MS/MS analysis.

2.4. LC--MS/MS analysis {#s0030}
-----------------------

Peptides from each gel fraction were separated on an Ultimate 3000 RSLC nano System utilising a PepMap C18 column, 2 µm particle size, 75 µm × 50 cm (Thermo Scientific, USA) and subsequently analysed on a QExactive mass spectrometer (Thermo Scientific, USA). Peptides were introduced into the mass spectrometer using an EASY-Spray™ nano source at a flow rate of 250 nl/min at approximately 400--600 bars. The 15 most intense precursors were selected for MS/MS analysis using higher-energy collisional dissociation (HCD) fragmentation and all fragmented precursor ions were actively excluded from repeated MS/MS analysis for 27 s.

2.5. Data analysis {#s0035}
------------------

### 2.5.1. Protein identification and relative abundance {#s0040}

RNAseq data of the schizont stage of *T. parva* has recently been made available in GenBank (BioSample accession SAMN03981746) and used to improve the annotation of the genome (da Silva, pers. comm.). The format for open reading frame (ORF) locus tags in the re-annotated genome of the Muguga strain has been changed from TPXX_YYYY ([@b0130]) to TpMuguga_0Xg0YYYY, where X stands for the chromosome number and YYYY for the gene number. This study relied on the re-annotated genome and the new format for *T. parva* ORF locus tags has been adopted.

Raw MS/MS data files were analysed with Peaks software (Bioinformatics solutions) using a database containing all Uniprot database entries for *R. appendiculatus* and the re-annotated proteome of *T. parva* (a total of 16,969 protein entries with 4084 *T. parva* and 12,884 *R. appendiculatus* protein entries, July 2016). A peptide false discovery rate (FDR) of 1.2% was applied and only proteins with unique peptide identification were included in the final sporozoite proteome list.

In order to rank the identified proteins by their abundance in the sample, an Exponentially Modified Protein Abundance Index (emPAI) was calculated using Mascot (Matrix Science) ([@b0170]). EmPAI is the exponential form of protein abundance index (PAI) minus 1 (emPAI = 10^PAI^ − 1) and is proportional to protein content in a protein mixture ([@b0170]). PAI is calculated by dividing the number of observed peptides by the number of observable peptides per protein.

### 2.5.2. Classification of subcellular localization of the identified *T. parva* sporozoite proteins {#s0045}

Proteins were classified according to their putative localization in the sporozoite using TargetP ([@b0110]). Trans-membrane domains (TMDs) were predicted by TMHMM Server v. 2.0 ([@b0190]), signal peptides (SP) by SignalP 4.1 ([@b0270]) and glycosylphosphatidylinositol (GPI)-anchor signal by GPI-SOM ([@b0115]).

### 2.5.3. Classification of the identified *T. parva* sporozoite proteins by orthology {#s0050}

We clustered all sporozoite protein coding sequences of *T. parva* with the complete predicted proteome of *Plasmodium falciparum* into putative orthologous groups using the OrthoMCL standalone software Version 2.0.2 ([@b0205]). The blast step of OrthoMCL was performed using an E-value cut-off of 1e^−10^, and minimum 70% sequence identity over 75% sequence coverage. *Plasmodium falciparum* 3D7 release of 26-06-2017 sequence data was downloaded from PlasmoDB ([@b0015])

3. Results {#s0055}
==========

3.1. Sporozoite proteome determination and relative quantification of expressed sporozoite proteins {#s0060}
---------------------------------------------------------------------------------------------------

LC--MS/MS was used to identify proteins expressed in a sample of semi-purified *T. parva* sporozoites. A complete list of all the proteins identified in this study is provided in [Supplementary Table S1](#s0110){ref-type="sec"}. In total 4780 proteins were identified of which 2007 originated from *T. parva* and 2773 from *R. appendiculatus*. Most proteins (3847) were identified with two or more peptides, while 933 protein identifications were based on a single peptide match, which includes 296 *T. parva* proteins ([Supplementary Table S2](#s0110){ref-type="sec"}). Thus, there is higher confidence in the identification of 1711 expressed parasite proteins. Sequence coverage of over 85% was achieved for three proteins, glyceraldehyde 3-phosphate dehydrogenase NAD binding domain, histone H2B.1 and ribosomal protein S21e, all encoded by single copy genes. Protein TpMuguga_03g00168, annotated as a hypothetical protein, was identified by as many as 94 unique peptides.

The 2007 *T. parva* sporozoite proteins that were identified represent approximately 50% of the 4084 proteins predicted to be encoded by the re-annotated *T. parva* genome (da Silva, pers. comm). Of the 2007 proteins, 1287 were further ranked by calculation of relative abundance in the sample using emPAI values ([Supplementary Table S3](#s0110){ref-type="sec"}), a parameter that is useful for obtaining an overview of proteome profiles with a wide dynamic range of concentrations (30 fmol to 1.8 pmol/μl) ([@b0170]). The 20 most abundant *T. parva* sporozoite proteins are shown in [Table 1](#t0005){ref-type="table"}. Even within this data set, there is a large range in the abundance of parasite proteins with histones being the most abundant. Other housekeeping proteins, e.g., ribosomal proteins, heat shock protein 70, phosphoglycerate mutase and glyceraldehyde 3-phosphate dehydrogenase, feature in this list.Table 1Abundant *Theileria parva* sporozoite proteins. Proteins detected from whole cell lysates of sporozoites are ranked by relative abundance in the sample. Known antigens are in bold face.ORF locus tag[a](#tblfn1){ref-type="table-fn"}Annotation[b](#tblfn2){ref-type="table-fn"}Mass (Da)emPAI[c](#tblfn3){ref-type="table-fn"}TpMuguga_04g00404Histone H2B.112,0407228.34TpMuguga_04g00071Histone H2B13,682900.39TpMuguga_04g00675Histone H411,362457.35TpMuguga_04g00690Phosphoglycerate mutase 1 family29,221105.17TpMuguga_04g00050Ribosomal protein S1917,15099.38TpMuguga_03g00655Hypothetical protein17,29696.5TpMuguga_04g00036AhpC/TSA family22,12084.68TpMuguga_02g00487Ribosomal protein S6e25,55367.36TpMuguga_02g00903Actin42,27060.62TpMuguga_04g00322Histone H2A13,49860.26TpMuguga_03g00067Hypothetical protein11,57254.06TpMuguga_01g00726elF-Tu GTP binding domain49,77952.64TpMuguga_01g00541Hypothetical protein24,79652.36TpMuguga_04g00383GAPDH NAD binding domain36,88351.37**TpMuguga_01g00701RAP-170,44147.73**TpMuguga_02g00148Heat shock 70 kDa protein71,44542.22TpMuguga_04g00179RanBP1 domain38,98241.34TpMuguga_03g00700Hypothetical protein23,99540.00**TpMuguga_03g00287Sporozoite P67 surface antigen75,45339.16**TpMuguga_01g00067Acyl CoA binding protein10,04339.11[^1][^2][^3]

3.2. Identification of known *T. parva* antigens within the sporozoite proteome {#s0065}
-------------------------------------------------------------------------------

The major circumsporozoite surface protein of *T. parva*, p67, which is a target of sporozoite neutralising antibodies ([@b0095]), was identified among the 20 most abundant proteins ([Table 1](#t0005){ref-type="table"}). Additional antigens that had been previously characterised were also identified in this study, e.g., p104 ([@b0105]), p150 microneme/rhoptry proteins ([@b0335]) and p32, a merozoite antigen ([@b0340]). We searched the sporozoite proteome data ([Supplementary Table S1](#s0110){ref-type="sec"}) for characterised schizont CD8 T cell antigens ([@b0140], [@b0145]) and found evidence for expression of all known CTL antigens (reviewed in [@b0240]) in the sporozoite stage. In contrast to CD8 T cell antigens, CD4 T cell antigens still require better characterization. CD4 antigens are presented by intact schizont-infected cells ([@b0030]) as well as cell extracts ([@b0020]). Soluble cytosolic parasite antigens stimulatory to CD4 T cell clones with fractions ranging between 10 and 24 kDa ([@b0035]) have been described, but further analysis and identification of the specific constituent proteins is required. However, among the most abundant sporozoite proteins we identified a protein that is homologous to a *Theileria annulata* protein annotated as rhoptry associated protein-1 (RAP-1) ([Table 1](#t0005){ref-type="table"}). RAP-1 of *B. bigemina* has been shown to be a CD4 T cell antigen ([@b0025]), suggesting that the *T. parva* RAP-1 is a potential CD4 T cell antigen.

3.3. *Theileria parva* sporozoite proteins associated with apicomplexan invasion of host cells {#s0070}
----------------------------------------------------------------------------------------------

Sporozoite secretory organelle proteins are typically located in the micronemes, rhoptries and dense granules in *P. falciparum* (reviewed in [@b0210]). To determine whether these proteins are present in *T. parva* sporozoites, we clustered our identified *T. parva* sporozoite proteins, using OrthoMCL, into orthologous groups with all *P. falciparum* genes. A total of 1105 proteins of the 2007 *T. parva* proteins were defined as *P. falciparum* orthologs ([Supplementary Table S4](#s0110){ref-type="sec"}) and we searched this list for apical organelle proteins. We identified *T. parva* orthologs of eight rhoptry proteins, three microneme proteins and a dense granule protein ([Table 2](#t0010){ref-type="table"}). Featured in the list are orthologs of *P. falciparum* apical membrane antigen 1 (AMA-1), a microneme protein essential during host cell invasion ([@b0350]), and cell-traversal protein for ookinetes and sporozoites (CelTOS), a malarial antigen mediating host cell invasion ([@b0180]). AMA-1 is a leading malaria vaccine candidate ([@b0285]), and orthologs of it are also found in *Neospora caninum* and *Toxoplasma gondii* ([@b0375]).Table 2Invasion organelle proteins. Proteins detected from whole cell lysates of *Theileria parva* salivary gland sporozoites are aligned by orthology with *Plasmodium falciparum* sporozoite proteins.Orthologous groupOrganismORF locus tag [a](#tblfn4){ref-type="table-fn"}Gene name[b](#tblfn5){ref-type="table-fn"}Annotation (reference)*Rhoptry proteins*OG5_142870*P. falciparum*PF3D7_1452000PfRON2Rhoptry neck protein 2 ([@b0050])*T. parva*TpMuguga_01g00014--Hypothetical proteinOG5_153587*P. falciparum*PF3D7_0817700RON5Conserved *Plasmodium* protein, unknown function ([@b0060])*T. parva*TpMuguga_01g01161--Hypothetical proteinOG5_153563*P. falciparum*PF3D7_1347500ALBA4Conserved *Plasmodium* protein, unknown function ([@b0295])*T. parva*TpMuguga_02g00645--Hypothetical proteinOG5_128020*P. falciparum*PF3D7_0932300PfM18AAPM18 aspartyl aminopeptidase ([@b0200])*T. parva*TpMuguga_01g01150--aspartyl aminopeptidaseOG5_145111*P. falciparum*PF3D7_0906000RNaseIIRNB-like protein, putative ([@b0295])*T. parva*TpMuguga_01g00396--Hypothetical proteinOG5_141731*P. falciparum*PF3D7_1361800GACConserved *Plasmodium* protein, unknown function ([@b0295])*T. parva*TpMuguga_01g00092--Hypothetical proteinOG5_129273*P. falciparum*PF3D7_0814200ALBA1DNA/RNA-binding protein Alba 1([@b0210])*T. parva*TpMuguga_03g00655Hypothetical proteinOG5_154281*P. falciparum*PF3D7_1006200ALBA3DNA/RNA-binding protein Alba 3 ([@b0210])*T. parva*TpMuguga_03g00067Hypothetical protein  *Microneme proteins*OG5_147452*P. falciparum*PF3D7_1133400AMA1Apical membrane antigen 1, AMA1 ([@b0055])*T. parva*TpMuguga_01g00650--Apical membrane antigen 1*falciparum*OG5_171217*P. falciparum*PF3D7_1216600CelTOSCell-traversal protein for ookinetes and sporozoites, putative ([@b0180])*T. parva*TpMuguga_01g00232--Hypothetical proteinOG5_135185*P. falciparum*PF3D7_0212900--Leu/Phe-tRNA protein transferase, putative ([@b0210])*T. parva*TpMuguga_02g00627--Leucyl/phenylalanyl-tRNA protein transferase  *Dense granules*OG5_126706*P. falciparum*PF3D7_0818200--14-3-3 protein, putative ([@b0210])*T. parva*TpMuguga_02g00607Hypothetical protein[^4][^5]

In *T. parva*, mobilisation of Ca^2+^ is necessary for successful sporozoite invasion of bovine lymphocytes and reagents that prevent Ca^2+^ mobilisation significantly curb zippering and internalisation stages of the entry process ([@b0315]). [Table 3](#t0015){ref-type="table"} shows 13 proteins identified in *T. parva* clustered with the *Plasmodium* proteins that play a role in calcium signalling, including calmodulin, an intracellular target for Ca^2+^ activation that acts on proteins such as guanylyl cyclases, protein kinases and phosphatases to aid in signal transduction.Table 3Proteins involved with calcium signalling. Proteins detected from whole cell lysates of *Theileria parva* salivary gland sporozoites are aligned by orthology with *Plasmodium falciparum* sporozoite proteins.Orthologous GroupOrganismORF locus tag[a](#tblfn6){ref-type="table-fn"}Gene name[b](#tblfn7){ref-type="table-fn"}Annotation (reference)OG5_126800*P. falciparum*PF3D7_1434200CAMCalmodulin*T. parva*TpMuguga_02g00717--CalmodulinOG5_129380*P. falciparum*PF3D7_1027700PfCEN1Centrin-1 ([@b0185])*T. parva*TpMuguga_01g00227--CentrinOG5_152981*P. falciparum*PF3D7_1140000CACarbonic anhydrase ([@b0210])*T. parva*TpMuguga_02g00412--Hypothetical proteinOG5_126600*P. falciparum*PF3D7_0717500PfCDPK4Calcium-dependent protein kinase 4 ([@b0160])*T. parva*TpMuguga_01g01073--Calmodulin-domain protein kinase*P. falciparum*PF3D7_1337800CDPK5Calcium-dependent protein kinase, ([@b0100])*T. parva*TpMuguga_02g00399--Calcium-dependent protein kinaseOG5_131887*P. falciparum*PF3D7_1123100CDPK7Calcium-dependent protein kinase 7 ([@b0210])*T. parva*TpMuguga_04g00518--Protein tyrosine kinaseOG5_127599*P. falciparum*PF3D7_1436600PKGcGMP-dependent protein kinase ([@b0210])*T. parva*TpMuguga_03g00511Protein tyrosine kinaseOG5_133188*P. falciparum*PF3D7_1138400GCalphaGuanylyl cyclase ([@b0275])*T. parva*TpMuguga_02g00848--Guanylyl cyclaseOG5_141757*P. falciparum*PF3D7_1246400MTIPMyosin A tail domain interacting protein ([@b0175])*T. parva*TpMuguga_01g00513--Myosin light chainOG5_126577*P. falciparum*PF3D7_1329100MyoCMyosin C([@b0360])*T. parva*TpMuguga_01g00774--Myosin COG5_126674*P. falciparum*PF3D7_1211900ATPase4Non-SERCA-type Ca^2+^ --transporting P-ATPase ([@b0040])*P. falciparum*PF3D7_0106300ATP6Calcium-transporting ATPase, putative ([@b0040])*T. parva*TpMuguga_01g00720--P-type ATPase*T. parva*TpMuguga_02g00524--Calcium-transporting ATPaseOG5_127599*P. falciparum*PF3D7_0934800PKAccAMP-dependent protein kinase catalytic subunit ([@b0210])*T. parva*TpMuguga_02g00378--cAMP-dependent protein kinase[^6][^7]

3.4. Putative *T. parva* surface proteins within the sporozoite proteome {#s0075}
------------------------------------------------------------------------

We used two methods to search for novel putative surface proteins. The first method was to use bioinformatics tools to predict the presence of GPI anchors and SP in proteins expressed by sporozoites. Only 12 proteins of the 2007 sporozoite proteins were found in this category ([Table 4](#t0020){ref-type="table"}). The list includes TpMuguga_01g00939 (gp34), a protein that undergoes GPI modification when expressed in mammalian cells and a schizont surface protein ([@b0370]). Since there is no direct evidence for addition of GPI anchors to parasite expressed proteins, we searched for enzymes of the GPI biosynthesis pathway encoded by the *T. parva* genome. Eight genes are essential for GPI synthesis in *P. falciparum* ([@b0065]). We found homologs of all eight genes in *T. parva* (TpMuguga_04g00759, TpMuguga_04g00881, TpMuguga_04g00525, TpMuguga_01g00169, TpMuguga_02g00201, TpMuguga_03g00397, TpMuguga_03g00846 and TpMuguga_02g00741) and identified that the latter four are expressed in the sporozoite proteome. This suggests the existence of GPI anchored proteins in *T. parva*, although this remains to be formally proven.Table 4Potential sporozoite surface proteins. Proteins detected from whole cell lysates of *Theileria parva* salivary gland sporozoites predicted to contain a glycosylphosphatidylinositol anchor and either transmembrane domain or signal peptide.ORF locus tag[a](#tblfn8){ref-type="table-fn"}Annotation[b](#tblfn9){ref-type="table-fn"}Unique peptides[c](#tblfn10){ref-type="table-fn"}emPAI[d](#tblfn11){ref-type="table-fn"}TMD[e](#tblfn12){ref-type="table-fn"}GPI-anchor[f](#tblfn13){ref-type="table-fn"}SP[g](#tblfn14){ref-type="table-fn"}TpMuguga_01g00438Hypothetical protein341.01011TpMuguga_01g00939Hypothetical protein (gp34)123.65111TpMuguga_01g00939Hypothetical protein123.65111TpMuguga_01g00972Hypothetical protein40.45111TpMuguga_01g01056Merozoite antigen (p32)126.78011TpMuguga_02g00412Hypothetical protein50.3011TpMuguga_02g00538Hypothetical protein311.34111TpMuguga_02g00553Hypothetical protein62.95111TpMuguga_02g00950Hypothetical protein2\<0.05111TpMuguga_03g00287Sporozoite p67 surface antigen5339.16111TpMuguga_04g00437104 kDa microneme/rhoptry antigen (p104)6012.35111TpMuguga_04g00615Probable N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase2\<0.05011[^8][^9][^10][^11][^12][^13][^14]

Secondly, we compiled from the literature a list of surface-exposed *P. falciparum* proteins and determined if orthologs exist within the *T. parva* sporozoite proteome. We identified orthologs of AMA-1 (TpMuguga_01g00650) and a hexose transporter (TpMuguga_01g01069) which were both identified by specific biotinylation of *P. falciparum* and *Plasmodium yoelii* surface proteins ([@b0210]).

3.5. *Theileria parva* proteins as candidate manipulators of host cell signalling leading to transformation {#s0080}
-----------------------------------------------------------------------------------------------------------

Lymphocyte transformation characterised by cancer-like cell phenotypes is solely dependent on viable schizonts and requires the schizont proteins to interact with and manipulate pathways regulating lymphocyte apoptosis, proliferation and gene expression ([@b0080], [@b0355]). We identified 17 proteins predicted to be manipulators of host cells ([@b0330]) in the sporozoite stage, suggesting that these proteins may be required immediately upon host cell entry. Transcripts for the genes encoding all 17 proteins are found in the RNAseq data from schizont-infected cells (see Section [2.5.1](#s0040){ref-type="sec"}), although at different levels ([Supplementary Table S5](#s0110){ref-type="sec"}). Among the identified proteins are members of two multigene families, the Sub-telomere-encoded Variable Secreted Protein (SVSP) gene family and the *T. annulata* schizont AT-hook (TashAT) gene family, or *T. parva* host nuclear (TpHN) gene family. TashAT proteins display a high degree of sequence conservation in their DNA-binding domains (AT-hook) in *T. annulata* but not in *T. parva* and contain an N-terminal signal sequence for transport across the parasite plasma membrane (reviewed in [@b0355]). TashAT family proteins are implicated in regulation of host gene expression and as accessory factors for parasite transcription ([@b0330]). Other families featured are DEAD-box RNA helicases with members implicated in alteration of RNA secondary structures and promotion of proto-oncogene c-myc expression (e.g., DDX6) ([@b0005]), thioredoxin/glutaredoxin family that are redox regulators and influence important signalling pathways such as nuclear factor kappa light chain enhancer of activated B cells (NF-kB) and activator protein-1 (AP1) pathways that are both activated in *Theileria*-transformed cells ([@b0330]). In addition, we identified *T. parva* Schizont-derived Cytoskeleton-binding Protein (TpSCOP), a protein that activates host NF-κB and mitogen-activated protein kinase (MAPK) pathways, leading to resistance to programmed host cell death ([@b0155]) and a peptidyl-prolyl isomerase, which has been demonstrated to interact with and lead to degradation of host ubiquitin ligase FBW7, thereby stabilising host c-JUN and promoting transformation of host cells ([@b0215]). Interestingly, the bulk schizont RNAseq data identified a high level of anti-sense transcription of the TpSCOP gene ([Supplementary Table S5](#s0110){ref-type="sec"}), suggesting that expression of this gene in the schizont stage may be under differential control. Resolution of the significance of this observation will require analysis of cell-cycle synchronised samples.

3.6. Sporozoite proteins involved in glycolysis and tricarboxylic acid (TCA) cycles {#s0085}
-----------------------------------------------------------------------------------

Proteins of the glycolytic pathway are conserved in most eukaryotic organisms and 10 genes encoding glycolytic enzymes have been found in *Theileria* genomes ([@b0130], [@b0255]). We identified expression of all the 10 enzymes of the glycolytic pathway in this study ([Fig. 1](#f0005){ref-type="fig"}) including lactate dehydrogenase (LDH), an enzyme that converts pyruvate, the last product of glycolysis, to lactate during low or no oxygen conditions. We also identified all the TCA cycle enzymes by MS ([Fig. 1](#f0005){ref-type="fig"}) with the exception that malate dehydrogenase is functionally replaced by malate-quinone oxidoreductase ([@b0130]), and was identified in the proteome data. Glutamate dehydrogenase was also identified in the proteome and glutamate has been suggested to be a supplementary intermediate for the TCA cycle ([@b0130]). The only functional link we have found between glycolysis and the TCA cycle is the presence of phosphoenolpyruvate carboxykinase. Neither glycerol kinase nor glycerol 3-phosphate dehydrogenase were identified, although *T. parva* encodes genes for both enzymes. These enzymes were identified with low levels in the schizont stage of *T. annulata* ([@b0365]).Fig. 1Most of *Theileria parva* proteins involved in glycolysis and tricarboxylic acid cycles were identified in this study. The glycolysis pathway is shown on the left and tricarboxylic acid cycle is shown on the right. Colour code for proteins: green, enzymes that were identified by MS; blue, enzymes encoded in the *T. parva* genome but not identified by MS; red, enzymes not encoded by the *T. parva* genome and not identified in this study. Enzymes identified by MS have open reading frame locus tags included in brackets (see below): HK, hexokinase (TpMuguga_01g00043); GPi, glucose 6-phosphate-isomerase (TpMuguga_03g00346); PFK, phosphofructokinase (TpMuguga_02g00577); FBP, fructose bisphosphatase; FBA, fructose bisphosphate aldolase (TpMuguga_01g00101); TPI, triosephosphate isomerase (TpMuguga_04g00464); Gly-3PDH, glycerol-3-phosphate dehydrogenase; Gly-K, glycerol kinase; GAPDH, glyceraldehyde phosphate dehydrogenase (TpMuguga_02g00858); PGK-1, phosphoglycerate kinase (TpMuguga_01g00965); PGM-1, phosphoglycerate mutase (TpMuguga_04g00690); ENO, enolase (TpMuguga_04g00700); PK, pyruvate kinase (TpMuguga_02g00134, TpMuguga_04g00607); LDH, lactate dehydrogenase (TpMuguga_01g01182); PC, pyruvate carboxylase; ACH, aconitate hydratase-1 (TpMuguga_01g01050); IDH, isocitrate dehydrogenase (TpMuguga_04g00620); OGDH, oxoglutarate dehydrogenase (TpMuguga_01g00262); SCL, succinyl coenzyme A ligase (TpMuguga_04g00660); SDH, succinate dehydrogenase (TpMuguga_01g00210); FH, fumarate hydratase-1 (TpMuguga_03g00078); MDH, malate dehydrogenase; MQOR, Malate: quinone oxidoreductase (TpMuguga_03g00758); CS, citrate synthase (TpMuguga_02g00666); PEPC, phosphoenolpyruvate carboxylase; PEPCK, phosphoenolpyruvate carboxykinase (TpMuguga_01g00495). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

3.7. Tick proteins {#s0090}
------------------

Searching the Uniprot database entries for *R. appendiculatus* with the LC--MS/MS data led to identification of 2773 tick proteins in addition to the *T. parva* proteins. The complete list of all the identified tick proteins is presented in [Supplementary Table S1](#s0110){ref-type="sec"}, but a detailed analysis of vector proteins will be reported elsewhere.

4. Discussion {#s0095}
=============

In this study, we employed a DE-52 ion-exchange column purification method to semi-purify *T. parva* sporozoites from infected tick salivary glands. Although tick proteins constituted 58% (2773/4780) of the total number of proteins of all proteins identified by LC--MS/MS and the Peaks and Mascot software packages, we were able to identify 2007 *T. parva* proteins expressed in the sporozoite life-cycle stage. This represents ∼50% of the total predicted re-annotated *T. parva* proteome of 4084 proteins (see Section [2.5.1](#s0040){ref-type="sec"}). Approximately 40% of these proteins are annotated as hypothetical proteins. Hence, our data provides evidence that real genes encode these proteins, although their functions remain unknown.

Studies on the proteome of *P. falciparum* sporozoite stages have reported identification of ∼13% ([@b0195]), ∼19% ([@b0125]) and ∼36% ([@b0210]) of the 5524 annotated *P. falciparum* genes using materials purified by DEAE-cellulose chromatography only ([@b0125], [@b0195]), and on 17% w/v Accudenz cushion followed by DEAE-cellulose chromatography ([@b0210]). The range of vector contamination is an important component of such studies and varied depending on the method of parasite purification. [@b0195] reported 65--89% mosquito protein contamination in the samples analysed, while [@b0210] reported 60.1% mosquito proteins in the sample, but had to perform double purification, initially on a 17% w/v Accudenz cushion then followed by DEAE-cellulose chromatography, to reduce mosquito protein contamination to 29% ([@b0195], [@b0210]). The presence of mosquito material in the sample was not discussed by [@b0125]). We managed to achieve low levels of vector protein contamination with a single DE-52 column purification step.

Positive identification of proteins by MS confers confidence in their presence, especially when the proteins are identified by more than one unique peptide hit. Of the 2007 parasite proteins, 1708 were identified by more than one hit, providing a high degree of confidence in 85% of the data. For the purposes of our current analyses we have, however, reported on the entire data set of 2007 proteins. Failure to identify *T. parva* proteins does not directly imply their absence in the sample. Peptides from proteins with low abundance may fall below the detection limit or are simply not sequenced by the mass spectrometer due to limited dynamic range and/or speed of instrument acquisition. Furthermore, unknown, complex, or amino acid modifications leading to alteration of the peptide mass can only be detected in some cases by the Peaks software. Finally, trypsin digestion of proteins with low or irregular arginine/lysine content can lead to very short and very long tryptic peptides that fall out of the acquired mass range, and may therefore not be detected.

Identification of *T. parva* sporozoite proteins through MS has allowed us to assess the proteomic component of the mammalian-infective stage of the parasite. We have also calculated the emPAI using Mascot to estimate the relative abundance ranking of proteins in the sample, which revealed a very high range of abundance with histones ranked with an emPAI of 60--7200 for the different histone subunits to an emPAI index of 39 for the major circumsporozoite p67 protein. Subunits of two enzymes within the glycolytic pathway, phosphoglycerate mutase and glyceraldehyde 3-phosphate dehydrogenase, are among the 20 most abundant sporozoite proteins detected ([Table 1](#t0005){ref-type="table"}). A high abundance of histones is not unusual. [@b0210] reported histones as the third most abundant protein in *Plasmodium* sporozoite proteome after the circumsporozoite protein and mitochondrial ATP synthase, subunit beta ([@b0210]).

A number of known antigens were identified within the sporozoite proteome including p67, a leading vaccine antigen, and previously described components of secretory organelles (e.g., p104 and p150) ([Table 4](#t0020){ref-type="table"}). RAP-1, a rhoptry antigen protective against *P. falciparum* infection in *Saimiri* monkeys ([@b0290]), was also identified ([Table 1](#t0005){ref-type="table"}). Unexpectedly, the polymorphic immuno-dominant molecule (PIM), a well-known antigen ([@b0345]), was not identified in this study even though p150, an antigen that is immunologically cross-reactive with PIM ([@b0335]), was identified. The PIM protein sequence contains a large repetitive domain rich in glutamine and proline amino acid residues that is devoid of lysine and arginine residues ([@b0345]). An in silico digestion of PIM with trypsin leads to prediction of few detectable tryptic peptides (data not shown). This may explain why we did not detect it. All schizont proteins that have been identified as CTL antigens are also expressed in sporozoites (emPAI range of 0.76--31.69). Some of these antigens are encoded by housekeeping proteins (e.g., hsp90) and translation elongation initiation factor 1A, so expression by sporozoites of some CTL antigens is not unexpected. The finding that all the known CTL antigens are expressed by sporozoites raises the question of whether infection of dendritic cells by sporozoites results in direct presentation of antigen for priming CTL responses in vivo, provided the antigen load is sufficient.

A study on the proteome of *T. annulata* schizont stage, in which 798 proteins were identified, failed to identify any member of SVSP and TashAT families ([@b0365]). In contrast, we identified members of both families in the sporozoite stage ([Supplementary Table S5](#s0110){ref-type="sec"}). There is increasing evidence pointing to a role of these proteins in host-parasite interaction, for instance SVSP epitope-tagged TpMuguga_03g00882 protein expressed in mammalian cells was found to translocate into the host nucleus, pointing to potential role in transforming host cells ([@b0305]). In addition, we identified other predicted host manipulation proteins such as DEAD-box RNA helicases, peptidases and two proteins, namely a peptidyl prolyl-isomerase and TpSCOP, demonstrated to play roles in host manipulation by stabilising c-JUN and activation of NF-kB, respectively ([@b0330], [@b0155], [@b0215]). Host cell manipulation is known to occur at the schizont stage and the finding of these proteins in the sporozoite stage suggests early expression of these proteins may be required, or multi-functionality of the proteins.

Sporozoite invasion of lymphocytes begins with binding events that trigger the mobilisation of Ca^2+^ within the sporozoites ([@b0080]). The free intracellular Ca^2+^ can be utilised by calmodulin to remodel itself structurally so as to act on downstream effectors such as calcium-dependent protein kinases (CDPKs), which have been shown to be useful for parasite infectivity. We detected both calmodulin and CDPKs in this study ([Table 3](#t0015){ref-type="table"}). We also detected other calcium signalling proteins including guanylyl cyclases, cGMP-dependent protein kinases and cAMP-dependent protein kinases, all of which are important for downstream calcium signalling and have been shown to be essential for sporozoite invasion (reviewed in [@b0080]).

In motile apicomplexans such as *Plasmodium*, free calcium induces microneme secretion by sporozoites to aid in gliding motility and host invasion ([@b0210]). Although *T. parva* sporozoites are immotile ([@b0320]), we identified orthologs of *Plasmodium* microneme components, including AMA-1, CelTOS and Leu/Phe-tRNA protein transferase ([@b0055], [@b0180], [@b0210]). These proteins may be involved solely in invasion processes, together with the detected rhoptry proteins (PfRON2, Conserved *Plasmodium* protein, PfM18AAP and RNB-like protein) and dense granules protein (14-3-3 protein) ([@b0295], [@b0200], [@b0050], [@b0060], [@b0210]). Since most of these proteins are still classified as hypothetical in *T. parva*, they present an opportunity for further analysis in studies aiming to block parasite invasion of host cells.

In conclusion, these data establish the expression profile of *T. parva* sporozoite proteins, the only such profile available to date. One or more of the newly identified proteins, in particular putative surface proteins, may prove to be effective vaccine candidates and might be combined with the major surface protein p67 to induce broader anti-sporozoite immunity, and protection against ECF.

Appendix A. Supplementary data {#s0110}
==============================

Supplementary Table S1Supplementary Table S2Supplementary Table S3Supplementary Table S4Supplementary Table S5
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[^1]: Open reading frame (ORF) locus tag refers to a unique *T. parva* gene identifier.

[^2]: Hypothetical protein is of unknown function; AhpC/TSA, alkyl hydroperoxide reductase subunit C/ thiol specific antioxidant family; elF, elongation factor; RAP-1, homolog of a *Theileria annulata* protein annotated as Rhoptry-associated protein 1; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; NAD, Nicotinamide adenine dinucleotide; RanBP1, Ran binding protein 1; CoA, co-enzyme A.

[^3]: emPAI, relative protein abundance in sample.

[^4]: Open reading frame (ORF) locus tag refers to a unique *T. parva* or *P. falciparum* gene identifier.

[^5]: Gene name is as defined in *P. falciparum*.

[^6]: Open reading frame (ORF) locus tag refers to a unique *T. parva* or *P. falciparum* gene identifier.

[^7]: Gene name is as defined in *P. falciparum*.

[^8]: Open reading frame (ORF) locus tag refers to a unique *T. parva* gene identifier.

[^9]: Hypothetical protein is of unknown function(s).

[^10]: Unique peptides refers to the total number of peptides identified matching the protein sequence that do not match any other protein in the database searched.

[^11]: emPAI, relative protein abundance in sample.

[^12]: Predicted using the TMHMM Server v. 2.0 (<http://www.cbs.dtu.dk/services/TMHMM/>).

[^13]: Predicted using the GPI-SOM (<http://gpi.unibe.ch/>).

[^14]: Predicted using the SignalP 4.1 server (<http://www.cbs.dtu.dk/services/SignalP/>).
